acquisitions

Funding agency gives to purchase Vancouver, B.C.-based biotech Zymeworks for $733M in money

Zymeworks CEO Kenneth Galbraith. (Zymeworks Picture) World funding agency All Blue Capital has provided to purchase Zymeworks, a public biotech…